Psychiatry and Mental Health

1-10 of 10

Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE Broadcast Replay
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Roger McIntyre, MD; Emmanuel Mignot, MD, PhD
1.00 credit
- Roger McIntyre, MD
- Emmanuel Mignot, MD, PhD
1.00 credit
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CE
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
Jose M. Rubio, MD, PhD
0.25 credits
- Jose M. Rubio, MD, PhD
0.25 credits
Precision Treatment Pathways for MDD and Comorbid Insomnia
Precision Treatment Pathways for MDD and Comorbid Insomnia
CME/CE
Precision Treatment Pathways for MDD and Comorbid Insomnia
Michael E. Thase, MD
0.25 credits
- Michael E. Thase, MD
0.25 credits
Updates in Major Depressive Disorder with Insomnia
Updates in Major Depressive Disorder with Insomnia
CME/CE
Updates in Major Depressive Disorder with Insomnia
Michael E. Thase, MD; Andrew Krystal, MD
0.50 credits
- Michael E. Thase, MD
- Andrew Krystal, MD
0.50 credits
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD; Jonathan M. Meyer
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
Psychiatry and Mental Health
Seltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
Michael E. Thase, MD
- Michael E. Thase, MD
Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Psychiatry and Mental Health
Sustained Antidepressant and Sleep Benefits With Adjunctive Seltorexant in MDD: Double-Blind and Long-Term Extension Data From the MD3001 Trial
Michael E. Thase, MD
- Michael E. Thase, MD
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Psychiatry and Mental Health
Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
Christoph U. Correll, MD
- Christoph U. Correll, MD
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Psychiatry and Mental Health
Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
Jonathan M. Meyer, MD
- Jonathan M. Meyer, MD
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
CME/CE
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Joseph F. Goldberg, MD
0.25 credits
- Joseph F. Goldberg, MD
0.25 credits

1-10 of 10

Title